Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)
~ Acceptance into ETP enables early FDA engagement to support development of the RaniPill® platform technology ~ ~ Acceptance into ETP enables early FDA engagement to support development of the RaniPill® platform technology ~
Covered in this story
Call it yourself
No calls on $RANI yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Rani Therapeutics Holdings →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.